Introduction: Who Should Seek Diagnostic Testing

Most people will experience symptoms of a viral respiratory infection at some point, and not everyone needs formal diagnostic testing. These infections affect your lungs, airways, nose, throat, and sinuses, making it harder to breathe comfortably. The decision about whether to get tested depends on several factors, including how sick you feel, your personal health situation, and what’s happening in your community.^[1]

If you develop symptoms like fever, cough, runny nose, sore throat, or body aches, you may wonder whether you need to see a healthcare provider. In many cases, viral respiratory infections are mild and improve on their own within one to two weeks without any specific medical treatment. However, certain people should consider getting tested and seeking medical attention sooner rather than later.^[3]

Testing becomes particularly important if you have risk factors that increase your chances of severe illness. These risk factors include being over 65 years old, being younger than 2 years old, having underlying medical conditions such as heart disease, lung disease, diabetes, or kidney problems, having a weakened immune system, or being pregnant. People with these conditions may benefit from early testing because if a specific virus like influenza or COVID-19 is identified, treatments may be available that can reduce the severity and duration of illness.^[1][6]

You should also consider diagnostic testing if your symptoms are severe or getting worse instead of better. Warning signs that warrant immediate medical attention include difficulty breathing, persistent high fever lasting more than three days, coughing up blood, symptoms lasting longer than expected, or feeling confused or extremely drowsy. These could indicate complications like pneumonia (lung infection) or other serious conditions that require specific diagnosis and treatment.^[4][3]

Another situation where testing is valuable is when knowing the specific virus would change your treatment plan. For influenza, COVID-19, and in some cases respiratory syncytial virus (RSV), antiviral medications may be prescribed. However, these treatments typically need to be started within a few days of symptom onset to be effective, making early testing important if you’re at higher risk for complications.^[16][6]

Testing may also be recommended for public health reasons. In healthcare facilities, nursing homes, or during outbreaks, identifying which specific virus is causing illness helps prevent spread to others. Healthcare providers may test patients to implement appropriate infection control measures and protect other vulnerable people in these settings.^[6]

Diagnostic Methods for Identifying Respiratory Infections

When you visit a healthcare provider with respiratory symptoms, they typically begin with a careful assessment of your symptoms and a physical examination. In many cases, especially for mild upper respiratory infections like the common cold, this clinical evaluation is sufficient. Healthcare providers can often tell whether you have a viral infection based on your symptoms, how long you’ve been sick, and what respiratory viruses are circulating in your community at that time.^[2][6]

The physical examination includes checking your temperature, listening to your lungs and heart, examining your throat and ears, and feeling your lymph nodes for swelling. Your provider will ask about your symptoms, including when they started, how severe they are, and whether they’re getting better or worse. This information helps distinguish between different types of respiratory infections and determines whether further testing is needed.^[2]

For most common colds caused by the hundreds of different rhinoviruses, specific testing isn’t usually performed because there’s no specific treatment and the infection resolves on its own. However, when it’s important to identify the specific virus causing your symptoms, several types of diagnostic tests are available.^[6]

Rapid Point-of-Care Tests

Rapid tests are quick diagnostic tools that can provide results in minutes to hours, often while you wait at your healthcare provider’s office. These tests typically look for antigens, which are proteins found on the surface of viruses. When a virus is present in sufficient quantities, the test can detect these proteins and confirm infection.^[6]

Rapid antigen tests are available for several common respiratory viruses, including influenza, COVID-19, and RSV. To perform these tests, a healthcare provider collects a sample by swabbing the inside of your nose or throat. The sample is then placed on a test strip or cartridge that contains special antibodies designed to recognize and bind to viral antigens. If the virus is present, a visible reaction occurs, typically showing a colored line or digital readout indicating a positive result.^[6]

The main advantage of rapid antigen tests is speed. Results are available quickly, allowing your healthcare provider to make treatment decisions during your visit. This is particularly valuable when antiviral medications might be beneficial, as these treatments work best when started early. However, rapid antigen tests have limitations. They are less sensitive than laboratory-based tests, meaning they’re more likely to miss infections when virus levels are low, producing false-negative results. If your rapid test is negative but your provider strongly suspects you have a particular infection, they may order a more sensitive laboratory test to confirm.^[6]

Laboratory-Based PCR Tests

Polymerase chain reaction (PCR) tests are the most sensitive and accurate diagnostic tools for detecting respiratory viruses. These tests work by detecting the genetic material (DNA or RNA) of the virus itself, rather than proteins on its surface. PCR technology can identify even very small amounts of virus, making these tests more reliable than rapid antigen tests.^[6]

Sample collection for PCR testing is similar to rapid tests, typically involving a nasal or throat swab. However, instead of being processed immediately at the point of care, the sample is sent to a laboratory where sophisticated equipment analyzes it. The process involves copying and amplifying any viral genetic material present in the sample millions of times until it reaches detectable levels. This amplification makes PCR tests extremely sensitive.^[6]

Many clinical laboratories now offer multiplex panels, which are PCR tests that can detect multiple different respiratory viruses from a single sample. These panels can simultaneously test for influenza A and B, RSV, COVID-19, and several other viruses that cause respiratory infections. This comprehensive approach is helpful when the specific cause of infection isn’t clear from symptoms alone, as many respiratory viruses produce similar symptoms.^[6]

The main drawback of PCR testing is that results typically take longer than rapid tests, usually anywhere from several hours to a few days depending on the laboratory. However, when available, PCR tests are generally preferred over rapid antigen tests for clinical purposes because of their superior accuracy.^[6]

Additional Diagnostic Approaches

In certain situations, healthcare providers may order additional tests to evaluate complications or rule out bacterial infections. These aren’t tests for the virus itself, but rather help assess how the infection is affecting your body.

Blood tests may be ordered to check for signs of infection, evaluate your immune system response, or look for complications. While blood tests can’t directly identify most respiratory viruses, they can provide information about the severity of infection and whether you might have a bacterial infection requiring antibiotics instead of or in addition to a viral infection.^[2]

If your healthcare provider suspects pneumonia or other lung complications, they may order a chest X-ray. This imaging test creates pictures of your lungs and can show areas of inflammation or fluid buildup that indicate lower respiratory tract infection. X-rays help distinguish between viral and bacterial pneumonia and assess the severity of lung involvement.^[2]

A sputum sample (mucus coughed up from your lungs) might be collected if you’re producing significant amounts of phlegm. This sample can be examined under a microscope and sent for culture to identify bacteria or, less commonly, tested for viruses. Sputum testing helps when there’s concern about bacterial superinfection complicating a viral respiratory infection.

For some respiratory viruses, blood tests can detect antibodies, which are proteins your immune system produces in response to infection. However, antibody testing isn’t useful for diagnosing acute respiratory infections because antibodies take time to develop, usually appearing several days to weeks after infection begins. Antibody tests are more helpful for determining whether you were infected in the past rather than diagnosing current illness.^[7]

When Testing Isn’t Necessary

It’s important to understand that diagnostic testing isn’t always needed or beneficial. For healthy adults and children with mild cold symptoms, testing typically doesn’t change management since the infection will resolve on its own with supportive care. Testing in these situations may add unnecessary cost and anxiety without improving outcomes.^[6]

Your healthcare provider uses clinical judgment to determine when testing is most appropriate. They consider factors like your risk for complications, the severity and duration of your symptoms, whether specific treatments might help, and local patterns of respiratory virus circulation in your community.^[2]

Diagnostic Testing for Clinical Trial Qualification

Clinical trials investigating new treatments, vaccines, or preventive strategies for respiratory viral infections use diagnostic testing as a standard tool to determine who can participate. These research studies have specific requirements, called eligibility criteria, which often include confirmation of infection through laboratory testing.

For trials studying acute respiratory infections, PCR testing is typically the gold standard used to confirm that potential participants actually have the viral infection being studied. Trial protocols usually require a positive PCR test result obtained within a specific timeframe, often within a few days of symptom onset. This timing requirement ensures that participants are at the right stage of infection for the intervention being tested to potentially work.^[6]

Some clinical trials test preventive interventions like vaccines or medications designed to stop infection before it starts. For these prevention trials, participants may undergo regular diagnostic testing throughout the study period, even when they don’t have symptoms, to detect any infections that occur. This surveillance testing helps researchers measure how well the preventive approach works by comparing infection rates between people receiving the intervention and those receiving a placebo.^[1]

Trials may also use multiplex PCR panels that simultaneously test for multiple respiratory viruses. This comprehensive testing helps ensure that study participants have the specific virus the trial is targeting and not a different respiratory pathogen. It also helps researchers understand whether the treatment works only against the targeted virus or provides broader protection.^[6]

For trials of antiviral treatments, diagnostic testing serves multiple purposes. Initially, it confirms infection and eligibility for the study. Throughout the trial, repeated testing helps measure how quickly the treatment clears the virus from your body compared to placebo or standard care. This measurement of viral clearance is an important outcome that helps researchers understand whether the treatment works and how effective it is.^[16]

Some trials collect additional samples for specialized laboratory testing that goes beyond standard clinical diagnostics. Researchers might measure the amount of virus present (called viral load) at different time points to understand how the infection or treatment affects viral replication. They might also analyze the specific genetic characteristics of the virus or test for markers in your blood that indicate how your immune system is responding to infection.^[6]

Clinical trials studying respiratory infections in people with underlying health conditions often require documentation of those conditions through medical records or additional testing. For example, a trial for people with asthma might require lung function tests to confirm the diagnosis and measure baseline respiratory capacity. Trials in older adults or people with weakened immune systems might include blood tests to assess immune function.^[1]

Testing requirements in clinical trials are clearly explained during the informed consent process before you decide to participate. Study staff will tell you exactly what samples will be collected, how often testing will occur, and how results will be communicated to you. In most cases, if testing reveals that you need medical care, the research team will help ensure you receive appropriate treatment, even if it means you’re no longer eligible to continue in the trial.